HBM Partners focuses on venture, growth and buy-out financings of private companies as well as investments in public companies.The HBM funds invest in entrepreneurial biopharma and other healthcare-related companies in Europe, North America, India and other Emerging Markets. Their team supports the growth of the portfolio companies through all
stages of development, focusing on adding value by leveraging its experience and HBM`s world-wide network in the industry. Investments usually range between $5 million to $50 million.
Industries: Health Care
Medical
Pharmaceutical
Biopharma
Biotechnology
Health Diagnostics
Life Science
Therapeutics
Hospital
Medical Device
Investment Stages: Seed
Late Stage Venture
Early Stage Venture
Location: Zug, Canton of Zug, Switzerland